Delivery Order HHSN271201700014I-75N95020F00002
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $1,027,022.00 cost-plus-fixed-fee delivery order contract to Sri International, a non-profit research institute, for non-clinical safety assessment of the drug candidate VK4-116 to support the treatment of severe pain disorders in human patients. This contract is part of the NCATS "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies"...
- This is a $756,613.00 firm fixed-price delivery order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services (HHS), to Sri International, a non-profit research and development institute. The award is for Task Order #001 under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master indefinite delivery/indefinite quantity (IDIQ) contract, and covers management and operations support...
- This is a $117,119.24 cost-plus-fixed-fee delivery order contract awarded to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the process development and synthesis of 100 grams of ARN0075039, a non-GMP material. It is part of the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award has no...
- This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) to SRI International, a nonprofit research and development institute. The purpose of the contract is to conduct purpose interaction safety studies in rats and dogs, with a period of performance from March 25, 2020 to March 24, 2021. The total potential value of the contract is $1,206,338.00. The contract is part of...
- This is a $434,985.00 cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Child Health and Human Development to Sri International, a non-profit research and development institute. The contract is for a Chemical Screening and Optimization Facility (CSOF) to provide drug substance and preparatory amount services, with a period of performance from September 29, 2022 to September 28, 2023. The contract...
- This is a delivery order award under the Nonclinical Services for Development of Interventional Agents indefinite delivery vehicle (IDV) to Sri International, a non-profit research and development institute. The $915,076.03 award is for Sri International to perform pre-clinical pharmacokinetic services for the National Institute of Allergy and Infectious Diseases, a civilian federal agency. The contract has no set-aside designation, reflecting Sri International's status as a large, established...
- This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime...
- Sri International has been awarded a cost-plus-fixed-fee delivery order valued at $571,190 by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to conduct Task Order 01 for Cocaine Interaction Safety Studies in Rats under the Toxicological Evaluations of Potential Medications IDIQ. The ordering period is from September 12, 2023 through September 11, 2024. The place of performance is West Menlo Park, California. No set-aside designation...
- This is a $4,734,236.00 delivery order under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" IDIQ contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The award is for non-clinical safety assessment of NES100 to support an analgesia indication, with a period of performance from September 18, 2020 to April 17, 2021. The prime contractor is Battelle Memorial...
- This is a cost-plus-fixed-fee delivery order task order awarded by the Department of Health and Human Services' National Institute on Drug Abuse (NIDA) to nonprofit research institute SRI International. The contract, valued at $479,933.60, is for toxicological evaluations of potential medications over a period of performance from September 7, 2018 to September 6, 2023. SRI International has extensive experience providing research, engineering, and technical services to federal agencies such as...
- HHSN271201700014IIndefinite Delivery Contract
- HHSN271201700014I-75N95020F00002Delivery Order
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order is part of a larger NCATS indefinite delivery, indefinite quantity (IDIQ) contract vehicle for contract research organization (CRO) support for in vitro and in vivo toxicology studies. Sri International has previously performed a variety of research and development services for government agencies like the Department of Defense, NASA, and NIH through prime contracts and subcontracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 3/12/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 2/9/21 | |
| Not listed | Not listed | $464.9k | 9/17/20 |